What's Happening?
Senate Appropriations Chair Susan Collins has released a fiscal year 2027 Labor-HHS-Education funding proposal that includes a $48.99 billion program level for the National Institutes of Health (NIH). This draft legislation, released on November 16, 2026,
represents a $500 million increase from the NIH's fiscal 2026 enacted comparison. The proposal aims to provide universities with a new benchmark for negotiating biomedical research funding. Key provisions in the draft include retaining restrictions on changes to NIH indirect cost policy and capping fiscal 2027 obligations for multiyear awards at the amount obligated for that purpose in fiscal 2025. The explanatory statement accompanying the draft expresses concern that funding all years of competing research project grants upfront could reduce the total number of grants NIH can support.
Why It's Important?
This Senate proposal is crucial for the future of biomedical research in the United States. The proposed increase in NIH funding, if enacted, would provide a significant boost to scientific discovery, disease prevention, and the development of new treatments. For universities and research institutions, it offers a potential for greater stability and expansion of their research programs. The retention of existing indirect cost provisions is important for institutions to cover the administrative and infrastructure costs associated with federal grants. However, the proposed cap on multiyear award obligations could impact long-term research planning and the ability of researchers to secure sustained funding for complex, multi-year projects. This draft sets the stage for ongoing negotiations between the Senate and House, ultimately determining the level of federal investment in health research.
What's Next?
This proposal is a draft and serves as a negotiating position in the broader federal budget discussions. It does not immediately translate into awarded funds for institutions. The current government funding measure expires on December 11, 2026, meaning negotiations will intensify to reach a full-year settlement for fiscal year 2027. Universities and research offices will use this draft to develop alternative research budget scenarios, planning for both current award support and potential future funding levels. The practical effect of this NIH proposal will depend on the final legislation that emerges from congressional negotiations and subsequent implementation by federal agencies. Research institutions will closely monitor these developments to understand the implications for their grant administration and research planning.
Beyond the Headlines
The debate over NIH funding levels reflects a continuous tension between fiscal conservatism and the recognized need for robust investment in scientific research. While a $500 million increase is positive, the concerns about multiyear award obligations highlight a broader challenge in federal funding: balancing the desire to support a greater number of new projects with the need for long-term stability for ongoing, complex research. This can create uncertainty for researchers whose projects require sustained funding over many years. The legislative process also reveals the intricate interplay between different branches of government and various stakeholders, all vying to shape the national research agenda. The outcome will not only impact scientific output but also the U.S.'s global competitiveness in biomedical innovation and its capacity to address future health crises.













